comprehensive -WSS

comprehensive

author：explore 2025-09-28 21:07:05 - browse：42946

empty test tubes in the hand. -- first opinion coverage from STAT — Adobe

The Food and Drug Administration on Friday announced its intention to start regulating tests developed in laboratories — closing the “Theranos loophole” that has allowed inaccurate tests to slip through the cracks.

Lawmakers came close last year to passing a bill that would have given the FDA this authority, but it was ultimately rejected by Republicans who sympathized with the labs in academic medical centers and hospitals that opposed the provision. FDA Commissioner Robert Califf said at the time that if the bill failed, the agency would take matters into its own hands.

The proposed rule fulfills that promise, adding lab diagnostics to the list of devices that fall under FDA enforcement — a move that patient groups and non-lab test makers support, and that laboratories are likely to dispute. When the FDA started regulating medical devices in 1976, lab-developed tests were simple and offered mostly to local patient populations. The agency generally allowed labs to use these tests without submitting proof of their efficacy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Kaiser's Risant Health gobbled up Geisinger. Who is next?

WSS

FDA's Pazdur wants cancer trials to range beyond China alone

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

How digital tools helped lower hypertension in marginalized patients

How digital tools helped lower hypertension in marginalized patients

Industry veterans launch new biotech VC with $310M

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

leisure time

comprehensive

hotspot

How to save PrEP access — and even expand it

Gilead might be held responsible for not developing a drug

23andMe had bad news about my health. I wish a person had delivered it

Doctors' information doesn't help them choose wisely when sick

BioMarin wins approval for gene therapy to treat hemophilia A

How digital tools helped lower hypertension in marginalized patients

FDA approval of Sarepta Duchenne genetic therapy gives me hope

HIV drugs protect against transmission, even in unprotected sex

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Letters to First Opinion on caregivers, digital health, and more

hotspot

Change Healthcare can notify patients about the breach, HHS says

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

BioAge raises $170M for combination therapy with Zepbound

What we’ve learned from the Aduhelm mess

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Industry veterans launch new biotech VC with $310M

focus

hotspot

leisure time

hotspot